MAPT and hippocampal atrophy: Elevated blood NfL levels are associated with hippocampal atrophy, reduced cerebral metabolic rates of glucose (CMRgl), and increased amyloid‐beta (Aβ) and tau deposition, as measured by positron emission tomography (PET) [20, 29, 30].